论文部分内容阅读
迄今,甲胎蛋白(AFP)作为肝癌的特异标记物被广泛应用。随着分子生物学的进展和高敏感方法的建立,AFP的检测手段日趋完善。本文采用固相放免法(SPRIA)对启东肝癌高发区不同人群进行血清中AFP测定,就其含量分布及意义予以探讨。材料与方法一、对象来源 1.健康献血员91例:取自市人民医院献血员队伍。2.HBsAg携带者279例:来源于前瞻观察对象。3.肝癌病人88例:为本所88～91年收治并经组织学证实的肝癌患者。二、检测方法
So far, AFP has been widely used as a specific marker for liver cancer. With the progress of molecular biology and the establishment of highly sensitive methods, detection means of AFP are maturing. In this paper, solid-phase radioimmunoassay (SPRIA) Qidong high incidence of liver cancer in different populations of serum AFP determination of its content and significance of the discussion. Materials and methods First, the object source 1 healthy blood donors 91 cases: taken from the city People’s Hospital blood donors team. 279 cases of HBsAg carriers: from prospective observation. 3. 88 cases of liver cancer patients: 88 to 91 years for our hospital and confirmed by histological liver cancer patients. Second, testing methods